Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne

Overview

Skin cleanser for daily used is essential and one of the most common questions asked by acne patients. There are studies reported beneficial effects of cleansers in acne treatment. Extracts of plants as active ingredients in skin cleansers are increasingly popular worldwide. Roselle is a common tropical shrub. Usually, the calyces of the plant have been used to make beverages but it also used in Thai traditional medicine for several purposes including as antiseptic and astringent. The extract of roselle showed antioxidant and keratolytic effects from previous studies which fit to the pathogenesis of acne. The aims of the study is to determine the safety and efficacy of skin cleanser contained roselle extract in acne.

Full Title of Study: “Randomized Double-Blind Case Control Study of Safety and Efficacy of Skin Cleanser Contained Hibiscus Sabdariffa Extract in Acne Treatment.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: July 2008

Detailed Description

Acne is one of the most common skin problems in teenagers and adolescents. Keys pathogenesis of the disease are 1.abnormal hypercornification of pilosebaceous duct,2.excess sebum production, 3.inflammation, 4.the present of Propionibacterium acnes. Treatments often include combination of topical and oral medications according to degree of acne severities. Acne medications can lead to drying and irritation of skin. Proper skin cleansing is important and can improve tolerability and efficacy of acne treatment. Traditional medicine with longstanding used of herbal ingredients for skin problems and beauty is increasing more popular. Hibiscus sabdariffa L.(Roselle) is used as food, drink and topical formulation for skin infection in Thai traditional medicine. The extract from calyces contained polyphenolic compounds and anthocyanins that showed antioxidant and keratolytic activities. There for skin cleanser with Roselle extract might be benefit to acne by loosen comedone, reduce Propionibacterium acne and prevent keratinocyte injury. The purposes of this study is to evaluate skin cleanser contained Roselle extract in two aspects ; 1. safety for irritation and allergic effects, 2. efficacy in acne as cleanser alone and as supportive care with others acne therapies.

Interventions

  • Other: skin cleanser contained Hibiscus sabdariffa extract
    • face washing 2-3 times/day
  • Other: marketed skin cleanser
    • face washing 2-3 times/day

Arms, Groups and Cohorts

  • Experimental: 1
    • skin cleanser contained Hibiscus sabdariffa
  • Active Comparator: 2
    • marketed skin cleanser

Clinical Trial Outcome Measures

Primary Measures

  • 1. Safety evaluation: Patch test 2. Efficacy evaluation: Acne lesions counts/ acne severity grading
    • Time Frame: 6 weeks

Secondary Measures

  • 1. Safety evaluation: “a.” Skin properties by visual and tactile features., “b.” Biophysical parameters of skin. 2.Efficacy evaluation: Patient assessments.
    • Time Frame: 6 weeks

Participating in This Clinical Trial

Inclusion Criteria

  • age 12-45 yrs,both sex – clinical diagnosis of mild to moderately severe acne vulgaris(grade 1-3) – have at least 10 facial acne lesions – not changing any acne treatment during study period – able to follow up according to protocol – Written informed consent Exclusion Criteria:

  • pregnant or breast feeding – severe acne(grade4 or nodulocystic acne) – treated with isotretinoin orally during the last 3 months – have other systemic disease or illness – have allergic history to Roselle

Gender Eligibility: All

Minimum Age: 12 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Thammasat University
  • Collaborator
    • National Research Council of Thailand
  • Provider of Information About this Clinical Study
    • Mali Achariyakul/Dr., Thammasat University
  • Overall Official(s)
    • Mali – Achariyakul, MD., Principal Investigator, Thammasat University
  • Overall Contact(s)
    • Mali – Achariyakul, MD., 66-02-9269473, mali1799@hotmail.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.